News & Analysis on Clinical Trial Services & Contract Research And Development
Chemicals supplier Aceto Corp has its sights set on opportunities in the generic drug sector after soaring active pharmaceutical ingredient (API) and intermediates sales helped it to a strong set of quarterly financials.
CMO Onyx Scientific will make a new anticancer API under a new deal with charity Cancer Research UK.
North Carolina, US-based contract research organisation (CRO), PPD, has expanded its product development consulting services into four new areas.
The FDA and USP have expanded their collaboration to ensure the quality of medicines by modernising tests and standards.
Chemistry services provider DavosPharma has added 100 per cent human antibodies to its discovery offering through a new alliance with Immunologix.
UK-based CRO, Quay Pharma, has invested in a variety of new equipment for use at its recently opened facility in Deeside, North Wales.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Sproxil, Intercell and Evolva Holding.
Quotient and KWS have partnered to support discovery and development in the fast growing antimicrobial agent sector.